IP Library Granted Patent US 9,120,850
Granted Patent B2
US 9,120,850 · App. 12/451,954 · Granted Sep 1, 2015

Biosensor for detection and visualisation of single-stranded DNA

Inventors: Mark Dillingham (London, GB); Stephen C. Kowalczykowski (Davis, CA); Martin Webb (London, GB)
Assignees: MEDICAL RESEARCH COUNCIL; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
C07K14/245G01N33/533G01N33/5308G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,120,850
App. No.
12/451,954
Granted
Sep 1, 2015
Kind
B2
Abstract

A modified protein of the single strand DNA-binding domain, SSB family comprising a detectable label is disclosed. The label has detectable characteristics which alter on binding single stranded DNA. The protein is thus useful in an assay for single stranded DNA.

Claims (23)

1. A labeled protein comprising one of the following sequences:

amino acids 2-178 of SEQ ID NO: 1 wherein at least one amino acid of positions 27, 89 or 93 is substituted with a fluorescently labeled cysteine;

amino acids 2-162 of SEQ ID NO: 7 wherein at least one amino acid of positions 27 and 89 is substituted with a fluorescently labeled cysteine;

amino acids 2-175 of SEQ ID NO: 8 wherein at least one amino acid of positions 27 and 89 is substituted with a fluorescently labeled cysteine;

amino acids 2-170 of SEQ ID NO: 9 wherein at least one amino acid of positions 23 and 82 is substituted with a fluorescently labeled cysteine;

amino acids 2-152 of SEQ ID NO: 10 wherein at least one amino acid of positions 22 and 83 is substituted with a fluorescently labeled cysteine;

amino acids 2-162 of SEQ ID NO: 11 wherein at least one amino acid of positions 26 and 88 is substituted with a fluorescently labeled cysteine; and

amino acids 2-179 of SEQ ID NO: 12 wherein at least one amino acid of positions 23 and 82 is substituted with a fluorescently labeled cysteine;

and wherein the fluorescent label emits a signal that is greater when the labeled protein is bound to single-stranded DNA as compared to when the labeled protein is not bound to single-stranded DNA.

2. The labeled protein according to claim 1 , wherein the labeled protein has an amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4.

3. The labeled protein of claim 1 , wherein the fluorescent label is a coumarin.

4. The labeled protein of claim 1 , wherein the fluorescent label is a rhodamine.

5. The labeled protein according to claim 1 , wherein the fluorescent label is selected from the group consisting of N-[2-(iodoacetamido)ethyl]-7-diethylaminocoumarin-3-carboxamide, 2-(4′maleimidylanilino)naphthalene-6-sulfonic acid, N-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide, Alexa Fluor 488, Alexa Fluor 546 and 6-iodoacetamidotetramethylrhodamine.

6. The labeled protein according to claim 5 , wherein the fluorescent label is 2-(4′maleimidylanilino)naphthalene-6-sulfonic acid.

7. The labeled protein according to claim 5 , wherein the fluorescent label is 6-iodoacetamidotetramethylrhodamine.

8. A method for detecting single stranded DNA in a sample comprising the steps of:

(i) mixing a sample comprising single stranded DNA with the labeled protein of claim 1 , and

(ii) detecting a change in the signal from the labeled protein arising from an interaction between the single stranded DNA and the labeled protein and thereby detecting single stranded DNA in the sample.

9. A method of screening for an inhibitor of a DNA processing enzyme

comprising

contacting the labeled protein of claim 1 with a cell in the presence of compound and measuring a first single stranded DNA level,

contacting the labeled protein with a cell in the absence of the compound and measuring a second single stranded DNA level, and

comparing the first single stranded DNA level to the second single stranded DNA level, wherein if the second single stranded DNA level is greater than the first single stranded DNA level, then the compound is an inhibitor of a DNA processing enzyme.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2012
From: UNIVERSITY OF BRISTOL
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 028403/0178 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2012
From: DILLINGHAM, MARK
To: THE UNIVERSITY OF BRISTOL
Reel/Frame 027947/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2012
From: WEBB, MARTIN
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 027947/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2012
From: KOWALCZYKOWSKI, STEPHEN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION
Reel/Frame 027950/0089 →
CONFIRMATORY LICENSE Recorded Jul 7, 2011
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026553/0251 →
CONFIRMATORY LICENSE Recorded Jul 6, 2011
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026546/0078 →
Priority Claims (1)
GB 0711328.5 · Jun 12, 2007 · national
Continuity (1)
Related Publication 20110177501A1 · Jul 21, 2011